Back to search

Article

PRDX4 Activates the Dual Enzymatic Functions of IRE1α to Promote Ovarian Cancer Progression

2026-04-08

Abstract excerpt

<title>Abstract</title> <p>Background Ovarian cancer is recognized as the most lethal gynecological malignancy, with high-grade serous carcinoma (HGSC) being the most prevalent and aggressive subtype. Due to the absence of typical early symptoms, the majority of patients are diagnosed at advanced stages, and effective biomarkers for early detection and prognosis remain elusive. Peroxiredoxin 4 (PRDX4), a cystein...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bbf9f748-3709-55b7-bffb-b9a36c3dc94d
DOI
10.21203/rs.3.rs-8481900/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PRDX4 Activates the Dual Enzymatic Functions of IRE1α to Promote Ovarian Cancer ProgressionDOI 10.21203/rs.3.rs-8481900/v1
PRDX1 as the potential marker to promotes pathogenetic progression of colorectal cancer via up-regulating the immune-proliferation pathwaySemantic proximity
Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancerSemantic proximity
In silico analysis reveals PRDX4 as a prognostic and oncogenic marker in renal papillary cell carcinomaSemantic proximity
Integrative analysis the characterization of peroxiredoxins in pan-cancerSemantic proximity
Identification of heme metabolism-related biomarkers in ovarian cancer and construction of a prognostic model via bulk RNA-Seq analysisSemantic proximity
Pan-Cancer Analysis of the Role of the Ferroptosis-Related Biomarker GPX4: A Potential Target for Prognosis and ImmunotherapySemantic proximity
Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancerSemantic proximity
Ryanodine Receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypesSemantic proximity
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancerSemantic proximity
Establishment and validation of a DNA damage repair gene based model for ovarian cancer typing and prognosisSemantic proximity
Human epididymis protein 4 and Lewis y enhance chemotherapeutic resistance in epithelial ovarian cancer through the p38MAPK pathwaySemantic proximity
Overexpression Of RNPEPL1 Predicts Poor Overall Survival In Ovarian CarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.